U.S. Pharmacist Weekly News Update
December 18, 2019

Obesity Medications
Under-Prescribed for
Patients Who Might Benefit

Guidelines are clear that medications should be considered in patients with BMI greater than 30, yet the drugs are being woefully under-prescribed, according to a new study. Less than 1.5% of a cohort of more than 2 million eligible adults filled any prescriptions for weight-loss drugs. Here is more information.


Using Birth Control Pills Linked to Smaller Hypothalamus Volumes
Oral contraceptives appear to have an unexpected effect on hypothalamus volume. Find out why a new study posits that there might be a correlation between that and greater anger and depression among birth control–pill users.

Thanks to Antiretroviral Therapy, Undetectable Equals Untransmittable HIV
Public health officials have been pushing the proven supposition that an HIV viral load that is undetectable because of antiretroviral therapy also means the infection is untransmittable. Now, a new survey has determined that the concept is becoming widely accepted. Here are more details.

Statin Usage Higher for Some When Managed by Pharmacists Versus Internists
Is pharmacist management of chronic disease therapy comparable to internal medicine providers? Find out how researchers determined that is the case with statin use in patients diagnosed with diabetes, with some patients actually more likely to receive appropriate treatment in the pharmacy group.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement Advertisement